Publications by authors named "Halah A Fallatah"
Cancers (Basel)
September 2024
Article Synopsis
- This study focused on metastatic renal cell carcinoma (mRCC), examining the survival outcomes of first-line immuno-oncological (ICI) regimens compared to single-agent tyrosine kinase inhibitors (TKIs) in Saudi Arabian patients.
- A total of 84 patients diagnosed with clear cell mRCC were analyzed, showing a median progression-free survival (PFS) of 9.7 months and an overall survival (OS) of 42.0 months, with no significant difference between treatment groups.
- The results indicated that first-line single-agent ICI therapy demonstrated promising anti-tumor activity and survival outcomes similar to both ICI-based combinations and TKIs, with liver metastasis and lower performance status being significant
